If you have mild to moderate kidney failure or raised levels of calcium in your urine (hypercalciuria) the amount of calcium in your blood and urine should be regularly monitored while you are taking this medicine.

If you have a history of kidney stones, the amount of calcium excreted in your urine should be monitored while you are taking Calcichew Tablets.

Use with caution in

  • People with a history of kidney stones (nephrolithiasis).
  • Kidney failure.
  • Sarcoidosis.
  • People with osteoporosis due to long periods of inactivity, for example prolonged bed-rest or paralysis of the legs.

Not to be used in

  • People with a high level of calcium in their blood (hypercalcaemia), for example as a result of bone marrow cancer or cancer that has spread to the bones, overactivity of the parathyroid glands (hyperparathyroidism), sarcoidosis or vitamin D poisoning.
  • People with very high levels of calcium in their urine (hypercalciuria).
  • Kidney stones.
  • Severely decreased kidney function that is not treated by kidney dialysis.
  • Calcichew tablets contain sorbitol and isomalt and should not be taken by people with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.
  • Calcichew tablets contain aspartame, which is a source of phenylalanine. As a result, Calcichew tablets may not be suitable for people with phenylketonuria or who are intolerant to phenylalanine.

This medicine should not be used if you are allergic to any of its ingredients. Please inform your doctor or pharmacist if you have previously experienced such an allergy. If you feel you have experienced an allergic reaction, stop using this medicine and inform your doctor or pharmacist immediately.